Trials / Completed
CompletedNCT02881710
Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Multicenter, prospective, uncontrolled study to evaluate variations in urinary concentrations of TIMP-2 and PCI IGFBP7 induced injection during a CT scan in intensive care patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | contrast product used to assess biomarkers variations |
Timeline
- Start date
- 2014-04-09
- Primary completion
- 2016-03-27
- Completion
- 2016-03-27
- First posted
- 2016-08-29
- Last updated
- 2021-09-21
Source: ClinicalTrials.gov record NCT02881710. Inclusion in this directory is not an endorsement.